2 Popular Artificial Intelligence (AI) Stocks to Sell Before They Fall 50% and 72% in 2026, According to Wall Street Analysts

Palantir and Intel have rallied sharply year-to-date (Palantir +140%, Intel +101%), but several Wall Street analysts warn the gains are unsupported by fundamentals and have issued steep 12‑month downside targets (RBC: Palantir $50, ~72% below ~$181; Wedbush/DBS: Intel $20, ~50% below ~$40.50). Palantir is lauded as a leader in AI/ML and posted strong Q3 results (revenue +63% to $1.1bn, non‑GAAP EPS $0.21) but trades at roughly 160x sales — the highest multiple in the S&P — raising concerns about an unsustainable valuation. Intel has secured a major foundry customer and hopes to capitalize on AI demand, yet it has ceded share to AMD and Arm, reported only 3% sales growth versus peer growth near the mid‑30s, faces execution risks around its 14A node and foundry strategy, and currently trades above its historical sales multiple, prompting analysts to recommend caution or avoidance.

Analysis

Palantir and Intel have both rallied sharply year to date (Palantir +140%, Intel +101%), yet bearish 12‑month targets from RBC and Wedbush/DBS imply steep reversals (Palantir to $50, ~72% downside from ~$181; Intel to $20, ~50% downside from ~$40.50), reflecting a strongly negative analyst backdrop. Palantir reported robust fundamentals—Q3 revenue up 63% to $1.1 billion and non‑GAAP EPS $0.21 with nine straight accelerations—and earns top industry recognition from Forrester as a leading AI/ML and decisioning platform, but it trades at ~160x sales (the highest in the S&P 500) against an AI platform market CAGR forecast of 38% through 2033, creating a material valuation risk. Intel has secured a major foundry customer (reportedly Microsoft) and hopes to ride AI demand, yet it continues to lose CPU share to AMD and Arm, delivered only 3% sales growth versus peers’ 36%/34%, faces execution risk around its 14A node and foundry economics, and currently trades at 3.3x sales versus a five‑year average of 2.4x. Given the combination of stretched multiples and execution uncertainty, the market impact is asymmetric: near‑term momentum could persist, but fundamentals suggest elevated downside risk absent clear proof of sustainable growth or execution improvement.

Key Decisions for Investors

• Avoid initiating new large positions in Palantir at current levels and limit exposure to a small, tactical stake or hedge given 160x sales valuation and a 72% implied downside, Monitor Palantir for valuation compression or evidence of durable margin expansion before increasing exposure
• Underweight or avoid Intel until the company demonstrates sustained revenue traction from foundry wins and reverses market‑share losses — specifically watch for recurring foundry revenue and a confirmed plan to fund/maintain leading‑edge nodes
• Consider redeploying exposure toward peers with demonstrably faster top‑line growth (AMD and Arm showed 36% and 34% sales growth respectively) or use hedges to protect existing PLTR/INTC positions while awaiting clearer execution signals